Overview

Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the utility of Yohimbine hydrochloride for facilitating fear extinction in a sample of patients with social phobia who will be treated with CBT.
Phase:
Phase 3
Details
Lead Sponsor:
Southern Methodist University
Treatments:
Yohimbine